Edition:
United States

NanoVibronix Inc (NAOV.OQ)

NAOV.OQ on NASDAQ Stock Exchange Capital Market

4.49USD
12 Dec 2017
Change (% chg)

$0.01 (+0.22%)
Prev Close
$4.48
Open
$4.42
Day's High
$4.49
Day's Low
$4.40
Volume
9,036
Avg. Vol
--
52-wk High
$4.89
52-wk Low
$3.68

Latest Key Developments (Source: Significant Developments)

Nanovibronix Announces Exclusive U.K. Distributor For Painshield
Tuesday, 5 Dec 2017 08:00am EST 

Dec 5 (Reuters) - Nanovibronix Inc ::NANOVIBRONIX ANNOUNCES EXCLUSIVE UK DISTRIBUTOR FOR PAINSHIELD(TM) PROVIDING PATIENTS AN ALTERNATIVE TO OPIOIDS AND SURGERY.SAYS ‍IT HAS SIGNED BHR PHARMACEUTICALS LTD AS ITS EXCLUSIVE DISTRIBUTOR FOR PAINSHIELD IN UNITED KINGDOM​.  Full Article

Nanovibronix ‍Expects To Complete Trial For Use Of Painshield In Patients With Trigeminal Neuralgia In Q1 Of 2018​
Wednesday, 29 Nov 2017 07:30am EST 

Nov 29 (Reuters) - Nanovibronix Inc ::NANOVIBRONIX REPORTS SUCCESSFUL INTERIM TRIAL RESULTS FOR USE OF PAINSHIELD(TM) IN PATIENTS WITH TRIGEMINAL NEURALGIA; REPRESENTS POTENTIAL ALTERNATIVE TO OPIOID AND SURGICAL INTERVENTIONS.NANOVIBRONIX INC - ‍EXPECTS TO COMPLETE TRIAL FOR USE OF PAINSHIELD IN PATIENTS WITH TRIGEMINAL NEURALGIA IN Q1 OF 2018​.  Full Article

Nanovibronix Inc to commence trial of anti-aging device
Tuesday, 14 Nov 2017 07:50am EST 

Nov 14 (Reuters) - Nanovibronix Inc :Nanovibronix to commence trial of anti-aging device in collaboration with a global cosmetics company.Execution of collaborative agreement to conduct a single-center clinical trial in conjunction with a global cosmetics company​.Following trial, the two companies plan to explore further collaboration opportunities​.  Full Article

BRIEF-Nanovibronix Announces Exclusive U.K. Distributor For Painshield

* NANOVIBRONIX ANNOUNCES EXCLUSIVE UK DISTRIBUTOR FOR PAINSHIELD(TM) PROVIDING PATIENTS AN ALTERNATIVE TO OPIOIDS AND SURGERY